Dr. Zeck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-687-3614
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Cytopathology, 2013 - 2014
George Washington UniversityResidency, Pathology-Anatomic and Clinical, 2009 - 2013- George Washington University School of Medicine and Health SciencesClass of 2009
Certifications & Licensure
DC State Medical License 2009 - 2027
MD State Medical License 2014 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones
Nature Communications. 2024-05-10 - 3 citationsAdjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones
Nature Communications. 2024-03-27 - Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones
Medrxiv. 2023-12-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
